111 related articles for article (PubMed ID: 8221824)
1. The political economy of pharmaceutical marketing channels: a conceptual framework.
Doucette WR; Schommer JC; Wiederholt JB
Clin Ther; 1993; 15(4):739-51. PubMed ID: 8221824
[TBL] [Abstract][Full Text] [Related]
2. Marketing concepts for pharmaceutical service development.
Grauer DW
Am J Hosp Pharm; 1981 Feb; 38(2):233-6. PubMed ID: 7211890
[TBL] [Abstract][Full Text] [Related]
3. Niche marketing: it's good for business.
Menighan TE
Am Pharm; 1991 Feb; NS31(2):51. PubMed ID: 2006612
[No Abstract] [Full Text] [Related]
4. Marketing to the mature population, Part 2: Developing marketing strategies.
Tootelian DH
Am Pharm; 1991 Feb; NS31(2):52-3, 56-9. PubMed ID: 2006613
[No Abstract] [Full Text] [Related]
5. Marketing and distribution of pharmaceuticals in the 21st century: two scenarios.
Hoff LC
Am Pharm; 1985 Mar; NS25(3):70-6. PubMed ID: 3984856
[No Abstract] [Full Text] [Related]
6. The pharmacist: key player in the home health market.
Huston P
Med Mark Media; 1985 Jul; 20(7):8-9, 12-21. PubMed ID: 10272850
[No Abstract] [Full Text] [Related]
7. Medical group management: a marketing orientation.
Bopp KD; Allcorn S
Health Care Strateg Manage; 1986 Sep; 4(9):14-23. PubMed ID: 10301113
[TBL] [Abstract][Full Text] [Related]
8. Redistribution of risk throughout the pharmaceutical industry.
Scheur BS
Med Interface; 1994 Oct; 7(10):77-80. PubMed ID: 10137569
[TBL] [Abstract][Full Text] [Related]
9. Neoliberalism and human services: threat and innovation.
Swenson S
J Intellect Disabil Res; 2008 Jul; 52(7):626-33. PubMed ID: 18482287
[TBL] [Abstract][Full Text] [Related]
10. A political economy perspective: why pharmacists may be reluctant to dispense generic medications.
Pelton LE; Strutton D; Smith MC
J Hosp Mark; 1994; 9(1):137. PubMed ID: 10142135
[TBL] [Abstract][Full Text] [Related]
11. Marketing child survival.
Grant JP
Assignment Child; 1984; (65-68):3-9. PubMed ID: 12266656
[TBL] [Abstract][Full Text] [Related]
12. Marketing and commercial challenges for anticancer products.
Stevens DM
In Vivo; 1996; 10(2):261-4. PubMed ID: 8744812
[TBL] [Abstract][Full Text] [Related]
13. Let the gamification begin.
Drell L
Mark Health Serv; 2014; 34(1):24-7. PubMed ID: 24741765
[No Abstract] [Full Text] [Related]
14. Intervention complexity--a conceptual framework to inform priority-setting in health.
Gericke CA; Kurowski C; Ranson MK; Mills A
Bull World Health Organ; 2005 Apr; 83(4):285-93. PubMed ID: 15868020
[TBL] [Abstract][Full Text] [Related]
15. Addressing the theoretical, practical and ethical challenges inherent in prospective health policy analysis.
Buse K
Health Policy Plan; 2008 Sep; 23(5):351-60. PubMed ID: 18664524
[TBL] [Abstract][Full Text] [Related]
16. Hospital marketing revisited.
Costello MM
Health Care Strateg Manage; 1987 May; 5(5):9-12. PubMed ID: 10283019
[TBL] [Abstract][Full Text] [Related]
17. Market drivers: preparing for the future.
Lewis TS
Med Device Technol; 1999; 10(1):17-21. PubMed ID: 10344870
[TBL] [Abstract][Full Text] [Related]
18. Marketing? In today's economy?
Hadley H
Conn Med; 2009 Jan; 73(1):52. PubMed ID: 19248578
[No Abstract] [Full Text] [Related]
19. [PROFAMILIA studies the effectiveness of contraceptive marketing programs in Colombia].
Perspect Int Planif Fam; 1987; (Spec No):39-40. PubMed ID: 12269053
[TBL] [Abstract][Full Text] [Related]
20. Legal aspects of on-line pharmacy: free movement of goods is not tantamount to free provision of services!
Michel L
Acta Chir Belg; 2004 Aug; 104(4):371-2. PubMed ID: 15469144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
